Searchable abstracts of presentations at key conferences on calcified tissues

ba0001pp411 | Osteoporosis: treatment | ECTS2013

Changes in low back pain and upper gastrointestinal symptoms in Japanese osteoporotic patients after switching to once-monthly oral minodronate from daily or weekly bisphosphonates

Okimoto Nobukazu , Sakai Akinori , Ikeda Satoshi , Yoshioka Toru , Teshima Kitau , Matsumoto Hidehiro , Tsurukami Hiroshi , Okazaki Yuichi , Nagashima Masato , Fukuda Fumio , Arita Shinobu

Introduction: Minodronate, a new-generation bisphosphonate (BP), is the first BP available as a once-monthly oral regimen in Japan. Aside from being a highly potent inhibitor of bone resorption, minodronate has been shown to possess antagonistic action against the P2X2/3 receptor, which has an important role in nociceptive transmission. The purpose of this study was to investigate the analgesic effects of once-monthly oral minodronate (MIN50 mg) on low back pain (LBP) associat...

ba0001pp413 | Osteoporosis: treatment | ECTS2013

Early response to once-monthly oral minodronate after switching from daily or weekly bisphosphonates in Japanese osteoporotic patients

Sakai Akinori , Ikeda Satoshi , Okimoto Nobukazu , Teshima Kitau , Arita Shinobu , Matsumoto Hidehiro , Tsurukami Hiroshi , Okazaki Yuichi , Nagashima Masato , Fukuda Fumio , Yoshioka Toru

Introduction: Minodronate, a highly potent, new-generation bisphosphonate (BP), is the first BP available as a once-monthly oral regimen in Japan. The aim of the present study was to investigate the effects of once-monthly oral minodronate on bone turnover markers (BTM) and bone mineral density (BMD) in osteoporotic patients previously using daily or weekly BPs in real clinical practice.Methods: We conducted a prospective multicenter study involving 11 i...

ba0001pp415 | Osteoporosis: treatment | ECTS2013

Patient preference and adherence to once-monthly oral minodronate in Japanese osteoporotic patients previously using daily or weekly bisphosphonates

Ikeda Satoshi , Sakai Akinori , Okimoto Nobukazu , Teshima Kitau , Arita Shinobu , Matsumoto Hidehiro , Tsurukami Hiroshi , Okazaki Yuichi , Nagashima Masato , Fukuda Fumio , Yoshioka Toru

Introduction: Bisphosphonates (BPs) are currently the mainstay of treatment in osteoporosis; however, the complex dosing regimens might interfere with long-term adherence, which provided the rationale to develop BPs with less-frequent dosing schedules. Minodronate (MIN 50 mg), a highly potent new-generation BP, is the first BP available as a once-monthly oral regimen in Japan. The aim of the present study was to investigate patient preference for, and adherence to, MIN 50 mg i...

ba0003pp109 | Cell biology: osteoblasts and bone formation | ECTS2014

Advanced glycation end products inhibit the mineralization of marrow stromal cells by binding the receptor for AGEs and increasing TGF-β expression and secretion

Yamaguchi Toru , Notsu Masakazu , Okazaki Kyoko , Tanaka Ken-ichiro , Ogawa Noriko , Kanazawa Ippei , Sugimoto Toshitsugu

We and others have recently showed that patients with type 2 diabetes mellitus (T2DM) have a higher risk for fracture, although they have normal or slightly higher bone mineral density (BMD). These findings suggest that bone fragility in T2DM, which is not defined by BMD, may contribute to fracture risk. Hyperglycemia accelerates the formation of advanced glycation end products (AGEs) and causes diabetic complications. AGEs including pentosidine are also known to cause bone fr...

ba0005p342 | Osteoporosis: pathophysiology and epidemiology | ECTS2016

Short-term smoking cessation improved bone formation in healthy male smokers

Watanabe Reiko , Tai Nobuyuki , Hirano Junko , Masaki Hiroaki , Okazaki Ryo , Inoue Daisuke

Background and Aim: Smoking increases fracture risk and contributes to COPD-associated osteoporosis. However, its impact on bone metabolism is largely unknown. We thus aimed to determine the effect of smoking cessation on bone metabolism.Subject and Method: In this prospective study, we recruited 29 healthy Japanese male subjects with smoking habit (37.7±8.2 years old, 16.9±11.3 pack years). Pulmonary function test was done before smoking cessa...